Cepheid's Q4 Revenues Spike 23 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Thursday that its fourth quarter 2013 revenues increased 23 percent year over year while its profit swung to a net loss.

For the three months ended Dec. 31, 2013, total revenues came in at $113.3 million, up from $92.4 million in the year-ago period and beating the consensus Wall Street estimate of $102.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.